Recs

8

Candela Burned by Costs: Fool by Numbers

On Tuesday, Jan. 23, aesthetic-laser maker Candela (Nasdaq: CLZR  ) released second-quarter 2007 earnings for the period ending Dec. 30, 2006.
  • Revenues were flat, coming in at $37.4 million versus $37.7 million last year.
  • Net income, however, fell 77% to $1 million, or $0.04 per share, versus last year's $4.5 million, or $0.19 per share.
  • Results were hurt by large increases in R&D spending, which soared to $4.6 million from $1.8 million in the year-ago quarter.
  • Rising inventories in the face of stagnant sales are a worrisome sign that Candela can't move its products.
  • Candela has a lowly one-star rating at Motley Fool CAPS.

(Figures in thousands, except per-share data)

Income Statement Highlights

Avg. Est.

Q2 2007

Q2 2006

Change

Sales

$42,900

$37.4

$37.7

(0.8%)

Net Profit

--

$1.0

$4.5

(77.3%)

EPS

$0.15

$0.04

$0.19

(79.0%)

Diluted Shares

--

23.4

23.5

(0.4%)



Get back to basics with a look at the income statement.

Margin Checkup

Q2 2007

Q2 2006

Change*

Gross Margin

47.52%

50.30%

(2.78)

Operating Margin

1.67%

17.60%

(15.93)

Net Margin

2.73%

11.96%

(9.23)

*Expressed in percentage points.

Margins are the earnings engine. See how they work.

Balance Sheet Highlights

Assets

Q2 2007

Q2 2006

Change

Cash + ST Invest.

$54.9

$52.6

4.3%

Accounts Rec.

$32.2

$32.8

(1.9%)

Inventory

$18.0

$13.9

29.8%



Liabilities

Q2 2007

Q2 2006

Change

Accounts Payable

$11.6

$8.0

45.0%

Long-Term Debt

$0

$0

N/A



Learn the ways of the balance sheet.

Cash Flow Highlights
No cash flow statement provided in press release. Boo!

Find out why Fools always follow the money.

Related Companies:

  • Palomar Medical Technologies (Nasdaq: PMTI  )
  • Cutera (Nasdaq: CUTR  )
  • Cynosure (Nasdaq: CYNO  )
  • Syneron Medical (Nasdaq: ELOS  )

Related Foolishness:

Fool by Numbers is designed to give you the raw earnings information in a timely fashion, putting all the numbers you need in one easy-to-read place. But at The Motley Fool, we believe numbers tell only part of the story, so check Fool.com for more of our in-depth discussion of what the numbers mean.

At the time of publication, Rich Duprey owned shares of Candela, but had no positions in any of the other companies mentioned in the article. Fool rules are here.


Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

DocumentId: 520470, ~/Articles/ArticleHandler.aspx, 5/25/2012 10:10:51 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 12,493.31 -36.44 -0.29%
S&P 500 1,319.90 -0.78 -0.06%
NASD 2,835.71 -3.67 -0.13%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

1/5/2010 4:00 PM
CLZR $3.00 Down +0.00 +0.00%
Candela Corp CAPS Rating: No stars
ELOS $10.86 Down -0.02 -0.18%
Syneron Medical CAPS Rating: ****
PMTI $8.65 Up +0.15 +1.76%
Palomar Medical Te… CAPS Rating: ***
CUTR $7.06 Down -0.09 -1.19%
Cutera, Inc. CAPS Rating: ***
CYNO $20.09 Down -0.12 -0.59%
Cynosure, Inc. CAPS Rating: **

Advertisement